WORKSHOP: Funding mechanisms for Investigator- Initiated Clinical Studies
ERA4Health Partnership is organising its second two-day workshop, “Funding Mechanisms for Investigator-Initiated Clinical Studies,” from February 8th to 9th in Brussels. This event is a golden opportunity for participants engaged in ERA4Health initiatives and invited speakers to delve into the intricacies of organising funding for multinational investigator-initiated clinical studies.
The agenda includes discussions around existing funding mechanisms, transnational funding models, and eligibility criteria and selection procedure for multinational investigator-initiated clinical studies.
This is a closed meeting for ERA4Health participants and invited speakers.
Investigator Initiated Clinical Studies (IICS)
Clinical research involves testing new discoveries by carrying out carefully controlled investigations on patients – known as clinical studies. This includes testing not only new or repurposed medicines, but also comparing various treatment regimens, medical devices, therapies without medicinal, diagnostic procedures, prevention measures, as well as optimizing the use of existing medicinal products and procedures to promote better health and welfare and/or cost saving to the society. Many of these studies and trials are non-commercial, initiated by investigators, usually driven by pressing public health needs and scientific opportunities, which do not offer a strong business case to private companies. This is referred to as investigator-initiated clinical studies (IICS) where the investigator conceives the research and develops the protocol.
Outcomes of the Workshop
This workshop serves as a dedicated platform for ERA4Health participants and invited speakers to discuss suitable models to support multinational IICS. Day 1 will feature in-depth discussions on various funding mechanisms for multinational investigator-initiated clinical studies, fostering a collaborative environment for knowledge exchange.
Importantly, the outcomes of Day 1 will be publicly summarized in a report, offering insights into the key takeaways and discussions that transpire during the event. However, it’s noteworthy that outcomes from Day 2 will be exclusively reserved for ERA4Health partners, ensuring a confidential space for strategic discussions and planning for the next phase of the Partnership.
This workshop promises a unique blend of expert insights, collaborative discussions, and practical knowledge sharing. Follow our social medias for real time updates & future events organized by the ERA4Health partnership.
